East Windsor, N.J. - Aurobindo Pharma Limited has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application Prednisone Tablets USP, 1mg. Aurobindo Pharma's Prednisone Tablets USP, 1mg, are an AB-rated generic equivalent to the reference listed drug (RLD), Meticorten Tablets, of Schering Corp Sub Schering Plough Corp.

Prednisone Tablets are indicated in the following conditions:

Endocrine Disorders

Rheumatic Disorders

Collagen Diseases

Dermatologic Diseases

Allergic States

Ophthalmic Diseases

Respiratory Diseases

Hematologic Disorders

Neoplastic Diseases

Edematous States

Gastrointestinal Diseases

Tuberculous meningitis with subarachnoid block or impending block when used concurrently with appropriate antituberculous chemotherapy; trichinosis with neurologic or myocardial involvement.

Contact:

279 Princeton Hightstown Road

East Windsor

NJ 08520

T: 866-850-2876

(C) 2021 Electronic News Publishing, source ENP Newswire